Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06360939

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

Led by Western Sydney Local Health District · Updated on 2026-02-18

60

Participants Needed

1

Research Sites

111 weeks

Total Duration

On this page

Sponsors

W

Western Sydney Local Health District

Lead Sponsor

U

University of Sydney

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this randomized clinical trial is to test the efficacy of stereotactic body radiation therapy (SBRT) in treating ventricular tachycardia (VT) in patients with advanced structural heart disease. The main questions it aims to answer are: * What is the efficacy of SBRT compared to catheter ablation (CA) in achieving a ≥ 75% reduction in VT burden at 6 months * What is the comparable safety profile of SBRT vs CA Researchers will compare SBRT and CA (standard of care).

CONDITIONS

Official Title

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Diagnosed with structural heart disease including ischaemic cardiomyopathy, non-ischaemic cardiomyopathy, or congenital heart disease with evidence of ventricular wall motion abnormalities, myocardial hypertrophy, or myocardial scar
  • History of recurrent monomorphic ventricular tachycardia demonstrated by at least one episode treated by implantable cardioverter defibrillator (ICD), sustained VT lasting over 30 seconds, or inducible VT on electrophysiological studies
  • PAINESD score of 9 or higher and/or at least moderate risk of VT recurrence or death based on the I-VT score
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Life expectancy less than 3 months
  • Catheter ablation considered futile or too risky by a cardiac electrophysiologist
  • Unwilling or unable to provide informed consent
  • Known cardiac channelopathies such as catecholaminergic polymorphic ventricular tachycardia, long or short QT syndrome, or Brugada syndrome
  • Contraindications to radiotherapy as determined by physicians
  • Pregnant or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Westmead Hospital

Westmead, Australia

Actively Recruiting

Loading map...

Research Team

S

Saurabh Kumar, MBBS | PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease | DecenTrialz